High materiality7/10
Kymera Therapeutics price target raised to $152 from $132 at Stifel
Why it may matterVerify against the original reporting
bullish_call
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Kymera Therapeutics price target raised to $152 from $132 at Stifel Nicolaus; posted price $117.67; price change since signal +$3.73.
- KYmera target $152; posted price $117.67; +$3.73 since signal.
Key facts
- 01
Target: $152
- 02
Posted price: $117.67
- 03
Analyst firm: Stifel Nicolaus
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.